{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T23:19:02Z","timestamp":1790983142057,"version":"4.1.0"},"reference-count":43,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2007,12,1]],"date-time":"2007-12-01T00:00:00Z","timestamp":1196467200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2007,12,1]],"date-time":"2007-12-01T00:00:00Z","timestamp":1196467200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annales d'Endocrinologie"],"published-print":{"date-parts":[[2007,12]]},"DOI":"10.1016\/j.ando.2007.04.002","type":"journal-article","created":{"date-parts":[[2008,1,26]],"date-time":"2008-01-26T20:31:41Z","timestamp":1201379501000},"page":"403-411","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":28,"title":["Adr\u00e9noleucodystrophie li\u00e9e \u00e0\u00a0l'X"],"prefix":"10.1016","volume":"68","author":[{"given":"P.","family":"Aubourg","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ando.2007.04.002_bib1","doi-asserted-by":"crossref","first-page":"3557","DOI":"10.1073\/pnas.0306431101","article-title":"Human CD34+ cells differentiate into microglia and express recombinant therapeutic protein","volume":"101","author":"Asheuer","year":"2004","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ando.2007.04.002_bib2","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1046\/j.1365-2605.1997.00066.x","article-title":"Signs of testicular insufficiency in adrenomyeloneuropathy and neurologically asymptomatic X-linked adrenoleukodystrophy: a retrospective study","volume":"20","author":"Assies","year":"1997","journal-title":"Int. J. Androl."},{"key":"10.1016\/j.ando.2007.04.002_bib3","doi-asserted-by":"crossref","first-page":"1860","DOI":"10.1056\/NEJM199006283222607","article-title":"Reversal of early neurologic and neuroradiologic manifestations of X-linked adrenoleukodystrophy by bone marrow transplantation","volume":"322","author":"Aubourg","year":"1990","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ando.2007.04.002_bib4","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/1043-2760(91)90039-P","article-title":"Adrenoleukodystrophy presenting as Addison's disease in children and adults","volume":"2","author":"Aubourg","year":"1991","journal-title":"Trends Endocrinol. Metab."},{"key":"10.1016\/j.ando.2007.04.002_bib5","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1056\/NEJM199309093291101","article-title":"A two-year trial of oleic ans erucic acids (Lorenzo' oil) as treatment for adrenomyeloneuropathy","volume":"329","author":"Aubourg","year":"1993","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ando.2007.04.002_bib6","series-title":"Hanbook of Clinical Neurology","first-page":"447","article-title":"X-linked adrenoleukodystrophy","author":"Aubourg","year":"1996"},{"key":"10.1016\/j.ando.2007.04.002_bib7","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1002\/(SICI)1098-1136(20000115)29:2<186::AID-GLIA13>3.0.CO;2-5","article-title":"The X-linked adrenoleukodystrophy enigma: how does the ALD peroxisomal transporter mutation affect CNS glia?","volume":"29","author":"Aubourg","year":"2000","journal-title":"Glia"},{"key":"10.1016\/j.ando.2007.04.002_bib8","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/S1525-0016(03)00002-9","article-title":"Transduced CD34+ cells from adrenoleukodystrophy patients with HIV-derived vector mediate long-term engraftment of NOD\/SCID mice","volume":"7","author":"Benhamida","year":"2003","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ando.2007.04.002_bib9","doi-asserted-by":"crossref","first-page":"1721","DOI":"10.1016\/j.bbamcr.2006.07.010","article-title":"X-linked adrenoleukodystrophy: Clinical, biochemical and pathogenetic aspects","volume":"1763","author":"Berger","year":"2006","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.ando.2007.04.002_bib10","doi-asserted-by":"crossref","first-page":"4849","DOI":"10.1210\/jc.2006-0076","article-title":"Premature Mortality in Patients with Addison's Disease: A Population-Based Study","volume":"91","author":"Bergthorsdottir","year":"2006","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.ando.2007.04.002_bib11","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1002\/ana.101","article-title":"Adrenoleukodystrophy: incidence, new mutation rate, and results of extended family screening","volume":"49","author":"Bezman","year":"2001","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.ando.2007.04.002_bib12","first-page":"357","article-title":"Gene therapy strategies for X-linked adrenoleukodystrophy","volume":"3","author":"Cartier","year":"2001","journal-title":"Curr. Opin. Mol. Ther."},{"key":"10.1016\/j.ando.2007.04.002_bib13","first-page":"856","article-title":"Assessment of adrenal function in women heterozygous for adrenoleukodystrophy","volume":"82","author":"el-Deiry","year":"1997","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.ando.2007.04.002_bib14","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1212\/01.WNL.0000149514.13580.84","article-title":"Spectroscopic evidence of cerebral axonopathy in patients with \"pure\" adrenomyeloneuropathy","volume":"64","author":"Dubey","year":"2005","journal-title":"Neurology"},{"key":"10.1016\/j.ando.2007.04.002_bib15","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1002\/ana.20643","article-title":"Diffusion tensor-based imaging reveals occult abnormalities in adrenomyeloneuropathy","volume":"58","author":"Dubey","year":"2005","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.ando.2007.04.002_bib16","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/S0166-2236(98)01319-8","article-title":"The neurobiology of X-linked adrenoleukodystrophy (ALD), a demyelinating peroxisomal disorder","volume":"22","author":"Dubois-Dalcq","year":"1999","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.ando.2007.04.002_bib17","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1212\/WNL.58.6.901","article-title":"Proton MR spectroscopic imaging predicts lesion progression on MRI in X-linked adrenoleukodystrophy","volume":"58","author":"Eichler","year":"2002","journal-title":"Neurology"},{"key":"10.1016\/j.ando.2007.04.002_bib18","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1148\/radiol.2251011040","article-title":"Proton MR spectroscopic and diffusion tensor brain MR imaging in X-linked adrenoleukodystrophy: initial experience","volume":"225","author":"Eichler","year":"2002","journal-title":"Radiology"},{"key":"10.1016\/j.ando.2007.04.002_bib19","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1212\/01.WNL.0000059546.15529.CB","article-title":"MRI and proton MRSI in women heterozygous for X-linked adrenoleukodystrophy","volume":"60","author":"Fatemi","year":"2003","journal-title":"Neurology"},{"key":"10.1016\/j.ando.2007.04.002_bib20","doi-asserted-by":"crossref","first-page":"1739","DOI":"10.1212\/01.WNL.0000164458.02141.06","article-title":"Magnetization transfer MRI demonstrates spinal cord abnormalities in adrenomyeloneuropathy","volume":"64","author":"Fatemi","year":"2005","journal-title":"Neurology"},{"key":"10.1016\/j.ando.2007.04.002_bib21","article-title":"Immunopathogenesis of adrenoleukodystrophy: Current understanding","author":"Hudspeth","year":"2006","journal-title":"J. Neuroimmunol"},{"key":"10.1016\/j.ando.2007.04.002_bib22","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1016\/j.ymgme.2006.10.001","article-title":"X-linked adrenoleukodystrophy: Very long-chain fatty acid metabolism, ABC half-transporters and the complicated route to treatment","volume":"90","author":"Kemp","year":"2007","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ando.2007.04.002_bib23","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.ymgme.2004.09.015","article-title":"Elongation of very long-chain fatty acids is enhanced in X-linked adrenoleukodystrophy","volume":"84","author":"Kemp","year":"2005","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ando.2007.04.002_bib24","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1148\/radiology.165.2.3659373","article-title":"Adrenoleukodystrophy: correlating MR imaging with CT","volume":"165","author":"Kumar","year":"1987","journal-title":"Radiology"},{"key":"10.1016\/j.ando.2007.04.002_bib25","first-page":"1227","article-title":"MR findings in adult-onset adrenomyeloleukodystrophy","volume":"16","author":"Kumar","year":"1995","journal-title":"AJNR Am. J. Neuroradiol."},{"key":"10.1016\/j.ando.2007.04.002_bib26","first-page":"3163","article-title":"Etiologic diagnosis of primary adrenal insufficiency using an original flow-chart of immune and biochemical marker","volume":"83","author":"Laurenti","year":"1998","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.ando.2007.04.002_bib27","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1212\/01.WNL.0000079050.91337.83","article-title":"Analysis of MRI patterns aids prediction of progression in X-linked adrenoleukodystrophy","volume":"61","author":"Loes","year":"2003","journal-title":"Neurology"},{"key":"10.1016\/j.ando.2007.04.002_bib28","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1002\/ajmg.1320440509","article-title":"Predictions of a 2-locus model for disease heterogeneity: application to adrenoleukodystrophy","volume":"44","author":"Maestri","year":"1992","journal-title":"Am. J. Med. Genet."},{"key":"10.1016\/j.ando.2007.04.002_bib29","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1038\/361726a0","article-title":"Putative X-linked adrenoleukodystrophy gene shares unexpected homology with ABC transporters","volume":"361","author":"Mosser","year":"1993","journal-title":"Nature"},{"key":"10.1016\/j.ando.2007.04.002_bib30","series-title":"The Metabolic and Molecular Bases of Inherited Diseases, 8th Ed","first-page":"3257","article-title":"X-linked adrenoleukodystrophy","author":"Moser","year":"2001"},{"key":"10.1016\/j.ando.2007.04.002_bib31","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1001\/archneur.62.7.1073","article-title":"Follow-up of 89 asymptomatic patients with adrenoleukodystrophy treated with Lorenzo's oil","volume":"62","author":"Moser","year":"2005","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.ando.2007.04.002_bib32","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1182\/blood-2003-10-3402","article-title":"Cerebral X-linked adrenoleukodystrophy: the international hematopoietic cell transplantation experience from 1982 to 1999","volume":"104","author":"Peters","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.ando.2007.04.002_bib33","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1093\/hmg\/11.5.499","article-title":"Late onset neurological phenotype of the X-ALD gene inactivation in mice: a mouse model for adrenomyeloneuropathy","volume":"11","author":"Pujol","year":"2002","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.ando.2007.04.002_bib34","doi-asserted-by":"crossref","first-page":"2997","DOI":"10.1093\/hmg\/ddh323","article-title":"Functional overlap between ABCD1 (ALD) and ABCD2 (ALDR) transporters: a therapeutic target for X-adrenoleukodystrophy","volume":"13","author":"Pujol","year":"2004","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.ando.2007.04.002_bib35","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1212\/WNL.52.4.810","article-title":"Neurophysiologic follow-up of long-term dietary treatment in adult-onset adrenoleukodystrophy","volume":"52","author":"Restuccia","year":"1999","journal-title":"Neurology"},{"key":"10.1016\/j.ando.2007.04.002_bib36","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1093\/brain\/120.7.1139","article-title":"Neurophysiological abnormalities in adrenoleukodystrophy carriers. Evidence of different degrees of central nervous system involvement","volume":"120","author":"Restuccia","year":"1997","journal-title":"Brain"},{"key":"10.1016\/j.ando.2007.04.002_bib37","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1212\/WNL.39.11.1415","article-title":"Dietary erucic acid therapy for X-linked adrenoleukodystrophy","volume":"39","author":"Rizzo","year":"1989","journal-title":"Neurology"},{"key":"10.1016\/j.ando.2007.04.002_bib38","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1016\/S0140-6736(00)02629-5","article-title":"Long-term beneficial effect of bone marrow transplantation for childhood onset cerebral X-linked adrenoleukodystrophy","volume":"356","author":"Shapiro","year":"2000","journal-title":"Lancet"},{"key":"10.1016\/j.ando.2007.04.002_bib39","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1159\/000112173","article-title":"Experience on therapy of adrenoleukodystrophy and adrenomyeloneuropathy","volume":"13","author":"Uziel","year":"1991","journal-title":"Dev. Neurosci."},{"key":"10.1016\/j.ando.2007.04.002_bib40","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1002\/1531-8249(20010201)49:2<186::AID-ANA38>3.0.CO;2-R","article-title":"Evolution of phenotypes in adult male patients with X-linked adrenoleukodystrophy","volume":"49","author":"Van Geel","year":"2001","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.ando.2007.04.002_bib41","doi-asserted-by":"crossref","first-page":"5512","DOI":"10.1016\/j.febslet.2005.09.014","article-title":"X-linked adrenoleukodystrophy mice demonstrate abnormalities in cholesterol metabolism","volume":"579","author":"Weinhofer","year":"2005","journal-title":"FEBS Lett."},{"key":"10.1016\/j.ando.2007.04.002_bib42","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1055\/s-2003-43254","article-title":"Quantitative proton magnetic resonance spectroscopy of children with adrenoleukodystrophy before and after hematopoietic stem cell transplantation","volume":"34","author":"Wilken","year":"2003","journal-title":"Neuropediatrics"},{"key":"10.1016\/j.ando.2007.04.002_bib43","unstructured":"X-linked Adrenoleukodystrophy Database. http:\/\/www.x-ald.nl\/."}],"container-title":["Annales d'Endocrinologie"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003426607000820?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003426607000820?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,12]],"date-time":"2025-09-12T22:41:34Z","timestamp":1757716894000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0003426607000820"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,12]]},"references-count":43,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2007,12]]}},"alternative-id":["S0003426607000820"],"URL":"https:\/\/doi.org\/10.1016\/j.ando.2007.04.002","relation":{},"ISSN":["0003-4266"],"issn-type":[{"value":"0003-4266","type":"print"}],"subject":[],"published":{"date-parts":[[2007,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Adr\u00e9noleucodystrophie li\u00e9e \u00e0\u00a0l'X","name":"articletitle","label":"Article Title"},{"value":"Annales d'Endocrinologie","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ando.2007.04.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2007 Published by Elsevier Masson SAS","name":"copyright","label":"Copyright"}]}}